Product How it works Pricing Blog FAQ About Contact
Quest Diagnostics

Quest Diagnostics (NYSE: DGX) net income

Quest Diagnostics reported a net profit of $992.0m for fiscal 2025, 13.9% more than in fiscal 2024 ($871.0m). Its net margin was 9.0%. Earnings per share were $8.87.

Net income, in millions of US dollars645.02016772.02017736.02018858.020191,43120201,9952021946.02022854.02023871.02024992.02025

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$992.0m+13.9%9.0%$8.87
2024$871.0m+2.0%8.8%$7.78
2023$854.0m−9.7%9.2%$7.59
2022$946.0m−52.6%9.6%$8.10
2021$1,995m+39.4%18.5%$15.85
2020$1,431m+66.8%15.2%$10.62
2019$858.0m+16.6%11.1%$6.36
2018$736.0m−4.7%9.8%$5.39
2017$772.0m+19.7%10.4%$5.63
2016$645.0m—8.9%$4.58

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the net income of Quest Diagnostics

How much did Quest Diagnostics earn in fiscal 2025?
Quest Diagnostics reported a net profit of $992.0m for fiscal 2025. In fiscal 2024 it reported a net profit of $871.0m.
What are the earnings per share of Quest Diagnostics?
They were $8.87 in fiscal 2025, compared with $7.78 in fiscal 2024.
What is the net margin of Quest Diagnostics?
In fiscal 2025 its net profit was 9.0% of its revenue.
What was the most profitable year for Quest Diagnostics?
Of its last 10 fiscal years, fiscal 2021, with $1,995m.
Where do the figures for Quest Diagnostics come from?
From the annual report (Form 10-K) that Quest Diagnostics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Quest Diagnostics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Quest Diagnostics: the Quest Diagnostics page · annual accounts · revenue · dividends paid · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.